Evidence map›Paper›PMID 28157211›Full record

ArticleScientific reports2017

Platelet activating factor-induced expression of p21 is correlated with histone acetylation.

Elisabetta Damiani, Nahum Puebla-Osorio, Bree M Lege, Jingwei Liu, Sattva S Neelapu, Stephen E Ullrich

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Elisabetta DamianiDipartimento di Scienze della Vita e dell'Ambiente, Universita' Politecnica delle Marche, Ancona, Italy.
Nahum Puebla-OsorioDepartment of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Bree M LegeDepartment of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Jingwei LiuDepartment of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Sattva S NeelapuDepartment of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
Stephen E UllrichDepartment of Immunology and The Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · USMarche Polytechnic University · IT

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Does UV-induced Unconventional Mast Cell Migration Activate Immune Suppression?R01CA131207 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ULLRICH, STEPHEN E · 2008 to 2012
$1.6M
NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA131207
6 · The paper itself

Abstract

Ultraviolet (UV)-irradiated keratinocytes secrete the lipid mediator of inflammation, platelet-activating factor (PAF). PAF plays an essential role in UV-induced immune suppression and skin cancer induction. Dermal mast cell migration from the skin to the draining lymph nodes plays a prominent role in activating systemic immune suppression. UV-induced PAF activates mast cell migration by up-regulating mast cell CXCR4 surface expression. Recent findings indicate that PAF up-regulates CXCR4 expression via histone acetylation. UV-induced PAF also activates cell cycle arrest and disrupts DNA repair, in part by increasing p21 expression. Do epigenetic alterations play a role in p21 up-regulation? Here we show that PAF increases Acetyl-CREB-binding protein (CBP/p300) histone acetyltransferase expression in a time and dose-dependent fashion. Partial deletion of the HAT domain in the CBP gene, blocked these effects. Chromatin immunoprecipitation assays indicated that PAF-treatment activated the acetylation of the p21 promoter. PAF-treatment had no effect on other acetylating enzymes (GCN5L2, PCAF) indicating it is not a global activator of histone acetylation. This study provides further evidence that PAF activates epigenetic mechanisms to affect important cellular processes, and we suggest this bioactive lipid can serve as a link between the environment and the epigenome.

Indexed as

Histone CodeAcetylationCell LineCyclin-Dependent Kinase Inhibitor p21HumansMast CellsPlatelet Activating FactorProtein Processing, Post-TranslationalReceptors, CXCR4CDKN1A protein, humanCXCR4 protein, humanCyclin-Dependent Kinase Inhibitor p21Platelet Activating FactorReceptors, CXCR4

Identifiers

PMID28157211
PMCPMC5291204
OpenAlexW2583783881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.